Clinical Trial: Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536841) titled 'Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.' on April 11.

Brief Summary: Approval Number protocol 020237 Board Name Ethics Committee of the Military Medical Clinical Center of the Southern Region. Board Affiliation Military Medical Clinical Center of the Southern Region, Ukraine. Board Contact Information Phone: [phone])

Study Start Date: May 01

Study Type: OBSERVATIONAL

Condition: Autoimmune Pancreatitis IgG4-Related Diseases Pancreatic Cancer Chronic Pancreatitis

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Military Medical...